Shivam leads the Finance team for South-East Asia & Taiwan Business Unit of Haleon. Haleon is world’s first pure-play Consumer Healthcare company with a clear purpose to deliver better everyday health with humanity. Haleon demerged from GSK and was independently listed on NYSE and LSE on 18th July 2022. Haleon’s leading brands are built on trusted science, innovation and human understanding and are trusted by millions of consumers globally. Some of the popular brands are Panadol, Sensodyne, Centrum, Caltrate, Polident, Eno etc.

South-East Asia & Taiwan Business Unit (BU) comprises of 11 markets and 3 manufacturing sites and, Shivam is accountable for Sales, Profit and Cash delivery for the BU. He is based in Singapore and serves on the Board of all Singapore based Legal Entities of Haleon.

Shivam has 16+ years of broad-based FMCG/H experience across Finance leadership roles in Commercial, Supply Chain, M&A, Strategy and Controllership. He has operated at Global, Regional, BU and Market level roles, based in London and Singapore.

Shivam has a MSc in Applied Mathematics from London School of Economics and a CIMA qualification.
Outside work, Shivam enjoys reading comic fantasy books by Terry Pratchett and binging on old British comedy sitcoms.